FR07C0023I2 - Adn codant le virus du papillome de type 18 humain - Google Patents

Adn codant le virus du papillome de type 18 humain

Info

Publication number
FR07C0023I2
FR07C0023I2 FR07C0023C FR07C0023C FR07C0023I2 FR 07C0023 I2 FR07C0023 I2 FR 07C0023I2 FR 07C0023 C FR07C0023 C FR 07C0023C FR 07C0023 C FR07C0023 C FR 07C0023C FR 07C0023 I2 FR07C0023 I2 FR 07C0023I2
Authority
FR
France
Prior art keywords
dna encoding
virus type
encoding human
papilloma virus
human papilloma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR07C0023C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR07C0023(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/408,669 external-priority patent/US5840306A/en
Priority claimed from US08/409,122 external-priority patent/US5820870A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR07C0023I1 publication Critical patent/FR07C0023I1/fr
Application granted granted Critical
Publication of FR07C0023I2 publication Critical patent/FR07C0023I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR07C0023C 1995-03-22 2007-03-20 Adn codant le virus du papillome de type 18 humain Active FR07C0023I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/408,669 US5840306A (en) 1995-03-22 1995-03-22 DNA encoding human papillomavirus type 18
US08/409,122 US5820870A (en) 1995-03-22 1995-03-22 Recombinant human papillomavirus type 18 vaccine
PCT/US1996/003649 WO1996029413A2 (en) 1995-03-22 1996-03-18 Dna encoding human papilloma virus type 18

Publications (2)

Publication Number Publication Date
FR07C0023I1 FR07C0023I1 (OSRAM) 2007-04-27
FR07C0023I2 true FR07C0023I2 (fr) 2012-08-03

Family

ID=27020342

Family Applications (1)

Application Number Title Priority Date Filing Date
FR07C0023C Active FR07C0023I2 (fr) 1995-03-22 2007-03-20 Adn codant le virus du papillome de type 18 humain

Country Status (22)

Country Link
EP (2) EP0817851B9 (OSRAM)
JP (1) JPH11502704A (OSRAM)
KR (1) KR100430698B1 (OSRAM)
CN (1) CN1100876C (OSRAM)
AT (1) ATE259879T1 (OSRAM)
AU (1) AU714533B2 (OSRAM)
CA (1) CA2215834C (OSRAM)
CZ (1) CZ291242B6 (OSRAM)
DE (4) DE122007000025I1 (OSRAM)
DK (1) DK0817851T5 (OSRAM)
EA (1) EA001092B1 (OSRAM)
ES (1) ES2213772T3 (OSRAM)
FR (1) FR07C0023I2 (OSRAM)
HU (1) HU223761B1 (OSRAM)
IL (1) IL117459A (OSRAM)
NL (3) NL300272I1 (OSRAM)
NO (1) NO322254B1 (OSRAM)
NZ (1) NZ305188A (OSRAM)
PL (1) PL184022B1 (OSRAM)
PT (1) PT817851E (OSRAM)
SK (1) SK284281B6 (OSRAM)
WO (1) WO1996029413A2 (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
ZA982950B (en) 1997-04-08 1998-10-19 Merck & Co Inc Stabilized human papillomavirus formulations
DK0973546T3 (da) * 1997-04-08 2004-06-28 Merck & Co Inc Stabiliserede formuleringer med human papillomavirus
ES2262333T3 (es) * 1998-08-14 2006-11-16 MERCK & CO., INC. Procedimiento para purificar particulas similares a virus de papilomavirus humano.
AUPP765398A0 (en) 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
EP1150712B1 (en) 1999-02-05 2008-11-05 Merck & Co., Inc. Human papilloma virus vaccine formulations
FR2795074A1 (fr) * 1999-05-21 2000-12-22 Inst Nat Sante Rech Med Polypeptides transporteurs d'acides amines, et en particulier du glutamate, et procedes de criblage de composes inhibiteurs ou activateurs de l'activite de transport
NZ542246A (en) * 2003-03-24 2007-12-21 Merck & Co Inc Optimized expression of HPV 31 L1 yeast
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
BRPI0811016B1 (pt) 2007-04-29 2021-09-21 Xiamen Innovax Biotech Co., Ltd. Proteína li truncada do papiloma vírus humano tipo 16
BRPI0815818A2 (pt) * 2007-04-29 2016-08-02 Beijing Wantai Biological Pharmacy Entpr Co Ltd proteína l1 truncada do papiloma vírus humano tipo 18
CN101440373B (zh) * 2007-11-23 2012-09-05 上海泽润生物科技有限公司 一种截短型的18型人乳头状瘤病毒主要衣壳蛋白l1基因
KR20120098580A (ko) * 2009-06-25 2012-09-05 글락소스미스클라인 바이오로지칼즈 에스.에이. 인간 파필로마바이러스（ｈｐｖ） 단백질 작제물 및 ｈｐｖ 질환을 예방하기 위한 이의 용도
CN103717741B (zh) * 2011-06-15 2016-04-13 中央大学校产学协力团 用于提高人乳头瘤病毒l1蛋白产量的方法
BR112014023092A8 (pt) 2012-03-18 2017-07-25 Glaxosmithkline Biologicals Sa Composição imunogênica, método para a prevenção de infecção ou doença por hpv em um indivíduo, e, kit
CN108276491B (zh) * 2018-02-05 2021-01-12 南京薇熙生物医药科技有限公司 一种可特异性识别hpv18 l1蛋白的单克隆抗体及其应用
MY197457A (en) 2019-07-19 2023-06-19 Sinocelltech Ltd Chimeric papillomavirus l1 protein
ES3017868T3 (en) 2022-07-07 2025-05-13 Permobil Ab Powered midwheel drive wheelchair with standing capability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3625257A1 (de) * 1986-07-23 1988-02-04 Behringwerke Ag Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika
DE4015044A1 (de) * 1990-05-10 1991-11-14 Behringwerke Ag Seroreaktive epitope auf proteinen des menschlichen papillomavirus (hpv) 18
DE122007000023I1 (de) * 1991-07-19 2007-08-09 Univ Queensland St Lucia Impfsstoff gegen Humanes Papillomavirus (typ 18)
EP0647140B1 (en) * 1992-06-25 2007-12-12 Georgetown University Papillomavirus vaccines
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
ES2242955T4 (es) * 1993-03-09 2010-04-12 The University Of Rochester Produccion de la proteina de la capside del virus del papiloma humano y particulas de tipo viral.

Also Published As

Publication number Publication date
ATE259879T1 (de) 2004-03-15
NO322254B1 (no) 2006-09-04
FR07C0023I1 (OSRAM) 2007-04-27
EP1422294A1 (en) 2004-05-26
EP0817851B1 (en) 2004-02-18
CN1185176A (zh) 1998-06-17
PL184022B1 (pl) 2002-08-30
WO1996029413A3 (en) 1996-11-28
DE69631586D1 (de) 2004-03-25
IL117459A (en) 2005-11-20
NZ305188A (en) 1999-11-29
NO974322D0 (no) 1997-09-19
DE122007000025I1 (de) 2007-07-12
EP0817851B9 (en) 2004-08-18
WO1996029413A2 (en) 1996-09-26
DK0817851T3 (da) 2004-08-16
DE69631586T9 (de) 2005-06-16
CA2215834A1 (en) 1996-09-26
SK284281B6 (sk) 2004-12-01
NL300272I1 (nl) 2007-05-01
NL300273I1 (nl) 2007-05-01
CA2215834C (en) 2007-06-12
CN1100876C (zh) 2003-02-05
KR100430698B1 (ko) 2004-07-15
MX9707208A (es) 1997-11-29
IL117459A0 (en) 1996-07-23
HU223761B1 (hu) 2005-01-28
DK0817851T5 (da) 2004-10-25
EA199700256A1 (ru) 1999-06-24
AU714533B2 (en) 2000-01-06
PL322333A1 (en) 1998-01-19
DE122007000031I1 (de) 2007-07-19
JPH11502704A (ja) 1999-03-09
CZ291242B6 (cs) 2003-01-15
CZ293697A3 (cs) 1998-02-18
EA001092B1 (ru) 2000-10-30
NO974322L (no) 1997-11-24
NL300271I1 (nl) 2007-05-01
PT817851E (pt) 2004-06-30
SK127897A3 (en) 1998-07-08
DE69631586T2 (de) 2005-01-27
ES2213772T3 (es) 2004-09-01
DE122007000030I1 (de) 2007-07-19
EP0817851A2 (en) 1998-01-14
HUP9801334A3 (en) 1999-04-28
HUP9801334A2 (hu) 1998-08-28
AU5314196A (en) 1996-10-08

Similar Documents

Publication Publication Date Title
FR07C0023I2 (fr) Adn codant le virus du papillome de type 18 humain
DE69634533D1 (de) Wegwerfartikel
FI971176A0 (fi) DNA-fotopilkkominen käyttäen teksapyriinejä
TR199700447A3 (tr) "Polimerizasyon katalizörü"
FI963201A0 (fi) Loisten häätöön käytettäviä aineita
ATE209045T1 (de) Hepatitis b impfstoff
FI98872B (fi) Parannettu portaittain säädettävä suodatin
DE69622331D1 (de) Mischapparat
ZA962245B (en) Dna encoding human papillomavirus type 18
FI964423A0 (fi) DNA-sekvenssit
EP0853629A4 (en) HEPADNAVIRUS RECEPTOR
DE59604205D1 (de) Neue Riechstoffe
FI971203L (fi) Tyyppiä 6A olevaa ihmisen papillomavirusta koodaava DNA
BR9508433A (pt) Peptídeos
DE69612897D1 (de) Mikrodatei
DE69509766D1 (de) Mikroemulsionen
ATE364686T1 (de) Bäckerhefe
IT1276074B1 (it) Rettoscopio monouso
DE69606985D1 (de) Verbessertes potentiometer
DE69730411D1 (de) Metastasen induzierende dna's
KR960028201U (ko) 개량 매트
FR2732339B1 (fr) Nouveaux agents de clivage d'adn a photo-induction
KR970005245A (ko) 교합기
KR970009717U (ko) 촉매 소제장치
BR7501397U (pt) Tapete descartável